Lapatinib Completed Phase 1 Trials for Tumors, Solid Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00984425The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
NCT00495872Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor